You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has chosen Boston, Massachusetts USA, as the location for the headquarters of Immunovia Inc, a wholly owned subsidiary of Immunovia AB. This new site is designed to accommodate a CLIA accredited reference laboratory for the Eastern USA as well as facilities for commercialization, coveAlready a subscriber Login You…
Novo Nordisk’s holding company Novo A/S is setting up a new unit for major acquisitions that can invest ten billion DKK annually, according to web magazine News Øresund. The ambition is to buy companies within the pharmaceutical, biotech and medtech sector in the Nordic countries and other parAlready a subscriber…
Cantargia and BioInvent International have announced that BioInvent has been contracted as manufacturer of Cantargia’s antibody CAN10 in preclinical development for the treatment of systemic sclerosis and myocarditis. CAN10 is fully humanized monoclonal antibody targeting IL1RAP. CAN10 has beenAlready a subscriber Login You have read all your free articles, to…
Oncopeptides has agreed with Kancera to take over Kancera’s drug development facility in Solna, Sweden. The agreement is an important step in the development of Oncopeptides’ pre-clinical operations and marks an additional reinforcement of the company's research capacity, it states. OncopeptiAlready a subscriber Login You have read all your free…
